Characteristics, Outcomes, and Severity Risk Factors Associated With SARS-CoV-2 Infection Among Children in the US National COVID Cohort Collaborative

Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19

(2021) Leora R. Feldstein et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Association of Intravenous Immunoglobulins Plus Methylprednisolone vs Immunoglobulins Alone With Course of Fever in Multisystem Inflammatory Syndrome in Children

(2021) Naïm Ouldali et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Trends in Geographic and Temporal Distribution of US Children With Multisystem Inflammatory Syndrome During the COVID-19 Pandemic

(2021) Ermias D. Belay et al.   JAMA Pediatrics

Characteristics and Disease Severity of US Children and Adolescents Diagnosed With COVID-19

(2021) Leigh Ellyn Preston et al.   JAMA Network Open

SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness

(2021) Aziz Sheikh et al.   LANCET

Lifting of COVID-19 restrictions in the UK and the Delta variant

(2021) Talha Khan Burki   Lancet Respiratory Medicine

Hospitalizations Associated with COVID-19 Among Children and Adolescents — COVID-NET, 14 States, March 1, 2020–August 14, 2021

(2021) Miranda J. Delahoy et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Underlying Medical Conditions Associated With Severe COVID-19 Illness Among Children

(2021) Lyudmyla Kompaniyets et al.   JAMA Network Open

Clinical Characterization and Prediction of Clinical Severity of SARS-CoV-2 Infection Among US Adults Using Data From the US National COVID Cohort Collaborative

(2021) Tellen D. Bennett et al.   JAMA Network Open

An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study

(2020) Lucio Verdoni et al.   LANCET

Characteristics and Outcomes of Children With Coronavirus Disease 2019 (COVID-19) Infection Admitted to US and Canadian Pediatric Intensive Care Units

(2020) Lara S. Shekerdemian et al.   JAMA Pediatrics

Severe and fatal forms of COVID-19 in children

(2020) M. Oualha et al.   ARCHIVES DE PEDIATRIE

Incidence of co-infections and superinfections in hospitalised patients with COVID-19: a retrospective cohort study

(2020) Carolina Garcia-Vidal et al.   CLINICAL MICROBIOLOGY AND INFECTION

A minimal common outcome measure set for COVID-19 clinical research

(2020) John C Marshall et al.   LANCET INFECTIOUS DISEASES

Multisystem Inflammatory Syndrome in U.S. Children and Adolescents

(2020) Leora R. Feldstein et al.   NEW ENGLAND JOURNAL OF MEDICINE

Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report

(2020)   NEW ENGLAND JOURNAL OF MEDICINE

Epidemiology, Clinical Features, and Disease Severity in Patients With Coronavirus Disease 2019 (COVID-19) in a Children’s Hospital in New York City, New York

(2020) Philip Zachariah et al.   JAMA Pediatrics

COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study

(2020) Florian Götzinger et al.   Lancet Child & Adolescent Health

Factors Associated With Severe SARS-CoV-2 Infection

(2020) Naïm Ouldali et al.   PEDIATRICS

Assessment of 135 794 Pediatric Patients Tested for Severe Acute Respiratory Syndrome Coronavirus 2 Across the United States

(2020) L. Charles Bailey et al.   JAMA Pediatrics

R Package for Pediatric Complex Chronic Condition Classification

(2018) James A. Feinstein et al.   JAMA Pediatrics

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for reporting observational studies

(2014) Erik von Elm et al.   International Journal of Surgery